New therapy for acute lymphoblastic leukaemia.
Emma
E
Wilkinson
D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D018572:Disease-Free Survival; D006801:Humans; D000080045:Inotuzumab Ozogamicin; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D016879:Salvage Therapy
D061067:Antibodies, Monoclonal, Humanized; D000080045:Inotuzumab Ozogamicin